Categroies
Nifedipine Controlled Release Tablets
This product has passed the quality and efficacy consistency evaluation of generic drugs
【Drug Name】
Generic name: preparation product
English name: Nifedipine Controlled-release Tablets
Pinyin: Xiaobendiping Kongshipian
[ingredients]
The main active ingredient of this product: nifedipine
Chemical name: dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate
Molecular formula: C17H18N2O6
Molecular weight: 346.34
【Properties】
This product is a pink film-coated tablet, with a reddish-brown and light yellow double-layer core after removing the coating.
【Indications】
1. High blood pressure
2. Coronary heart disease
Chronic stable angina (exertion angina)
【Specification】
30mg
【Dosage】
Unless otherwise prescribed by a physician, the following dosages are recommended for adults:
1. Hypertension:
30mg at a time (1 tablet at a time), once a day
2. Coronary heart disease:
Chronic stable angina (exertion angina)
30mg at a time (1 tablet at a time), once a day
The usual initial dose for treatment is 30 mg daily.
Concomitant use with CYP 3A4 inhibitors or CYP 3A4 inducers may require dose adjustment of nifedipine or omission of nifedipine.
Course of treatment: The time of medication should be determined by the doctor.
Medication method: Usually the whole tablet is swallowed with a small amount of liquid, and the time of taking the medicine is not limited by the meal time. Grapefruit juice should be avoided.
special population
Patients with hepatic impairment
Dosing in patients with mild, moderate, or severe hepatic impairment based on Child Pugh score should be carefully monitored and dose reductions may be required. The pharmacokinetics of nifedipine have not been studied in patients with severe hepatic impairment.
[Adverse reactions], [Precautions] Please refer to the instruction manual for details
【Taboo】
· This product is contraindicated in those who are known to be allergic to nifedipine or any ingredient in this product.
Nifedipine is contraindicated in cardiogenic shock.
Contraindicated in patients with KOCK pouch (ileostomy after proctocolectomy)
·Due to enzyme induction, when co-administered with rifampicin, nifedipine cannot achieve effective plasma levels. Therefore, it should not be used in combination with rifampicin.
Nifedipine is contraindicated within 20 weeks of pregnancy and lactating women.
【storage】
Keep away from light, keep sealed below 30°C, and take it immediately after taking it out of the aluminum-plastic plate.
Keep medicines out of the reach of children.
【Package】
Polyvinyl chloride/polyvinylidene chloride solid pharmaceutical composite hard sheet and aluminum foil for pharmaceutical packaging, 10 pieces/board×1 board/box; 10 pieces/board×2 boards/box; 10 pieces/board×4 boards/box .
【Validity】
24 months tentatively
Note that this product cannot be taken after the expiration date.
【Marketing Authorization Holder】
Company name: Hefei Huafang Pharmaceutical Technology Co., Ltd.
【manufacturer】
Company Name: Hefei Spree Pharmaceutical Co., Ltd.
keyword:Chemical products,Chinese medicine products
Related products
Inquiry
Mobile